Vaccine policy, decision processes and outcomes vary widely across Europe. The objective
was to map these factors across 16 European countries by assessing (A) national …

Background Coinciding with the release of the first Chinese domestic human papillomavirus
(HPV) vaccine Cecolin in 2019, and the substantial advancements in cervical cancer …

Over a decade has passed since the first human papillomavirus (HPV) vaccine was
introduced. These vaccines have received unequivocal backing from the scientific and …

Background: Adolescent HPV (Human Papilloma Virus) vaccination is yet to be introduced
as a mandatory program in Poland. Polish literature on factors associated with adolescent …

Background Ukrainians numbering approximately 1.2 million are the largest migrant group
in Poland. Data on vaccination coverage among migrants are not collected in EU, including …

Vaccine hesitancy is increasing and failure to vaccinate is well-recognised in Europe as a
contributing factor to outbreaks of infectious diseases. In Lothian and Scotland, low vaccine …

Abstract Of the 2,635,000 new cancer cases (excluding non-melanoma skin cancers)
occurring in the European Union (EU) in 2012, it is estimated that approximately 185,000 …

Background Human papillomavirus (HPV) is one of the most common sexually transmitted
infections and can be prevented by vaccination. The purpose of this study is to gain a better …

Background: Human papillomavirus (HPV) is one of the most common causes of sexually
transmitted disease (STD) in humans. HPV is associated with gynecologic malignancy and …

Objective: National cervical cancer prevention program has been initiated in Indonesia since
April 2015 and the ministry of health has started efforts to integrate the HPV Vaccine in the …